Actively Recruiting
ABCSG R07 Rectal Cancer Registry Observational Study Documenting Treatments and Outcomes for Localized, Non-metastatic Rectal Cancer in Austria
Led by Austrian Breast & Colorectal Cancer Study Group · Updated on 2026-10-30
600
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting information on treatments used for patients with localized rectal cancer in Austria to understand current practices and outcomes. This observational study focuses on patients receiving total neoadjuvant therapy TNT or those with dMMRMSI-H disease, documenting their treatment regimens and responses. There are no interventions assigned by the study, and treatment decisions remain with the participants physicians. Participants are documented retrospectively if treated between June 2020 and study start June 2005 for dMMRMSI-H cases and prospectively from study start through the following three years. The study collects data on various treatment approaches, including different TNT protocols and immunotherapy, reflecting real-world care without altering any treatment plans. During the study, only information and samples gathered as part of routine care are used. Researchers monitor treatment responses at surgery, types of treatments and surgeries used, recurrence rates, survival outcomes, and treatment adherence over time. Participation does not add health risks or individual benefits, and the study aims to follow participants for up to three years after their primary treatment.
CONDITIONS
Brief Title
ABCSG R07 Rectal Cancer Registry
Research Team
M
Miriam Muehlburger, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here